Shukra Pharmaceuticals Share Price

Shukra Pharmaceuticals Share Price

31.46
+2.86 (10.00%)
BSE
BSE: 524632 | Pharmaceuticals | Small Cap | as on 05 Jun, 2026 • 03:29 PM IST
Buy

Shukra Pharmaceuticals Annualised Returns

1 Year

▲128.14%

3 Years

▲102.43%

5 Years

▲148.92%

10 Years

▲59.27%

Shukra Pharmaceuticals Share Price Today


As of 6 Jun 2026, Shukra Pharmaceuticals share price is ₹31.5. The stock opened at ₹28.5 and had closed at ₹28.6 the previous day. During today’s trading session, Shukra Pharmaceuticals share price moved between ₹28.51 and ₹31.46, with an average price for the day of ₹29.98. Over the last 52 weeks, the stock has recorded a low of ₹12.97 and a high of ₹65.26. In terms of performance, Shukra Pharmaceuticals share price has declined by 21.6% over the past six months and has increased by 128.14% over the last year.

Shukra Pharmaceuticals Stock Performance

1W Return8.52
1Y Return132.69
Today's Low28.51
Prev. Close28.60
Mkt Cap (Cr.)1,377.57
1M Return-1.75
3Y Return811.88
52-Week High65.26
Open28.51
PE Ratio62.92
6M Return-21.60
Today's High31.46
52-Week Low12.97
Face Value1

Shukra Pharmaceuticals Share Price Chart

Shukra Pharmaceuticals Company background

Founded in: 1993
Managing director: Dakshesh Shah
Shukra Pharmaceuticals Limited, formerly known Relish Pharmaceuticals Limited was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on September 22, 2016. The Company is presently engaged in the business of manufacturing and trading of pharmaceuticals formulations and laboratory testing. The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others.The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum), Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat.The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus), Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Makers Laboratories Limited, Agenta Pharma Limited etc.The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world.In FY 201314, the Company got approval from Honble High Court of Gujarat for revival of Relish Pharmaceuticals Limited and Amalgamation of Proper Dealcomm Private Limited with the erstwhile Relish Pharmaceuticals Limited and Reorganization of Share Capital of Relish Pharmaceuticals Limited through the Scheme of Arrangement vide Honble High Court of Gujarat order dated 20 December, 2013.The Company has achieved WHOGMP certification, successfully securing a partnership with Meril Healthcare for robotic surgery projects in October 2025.

Shukra Pharmaceuticals Financial Highlights


For the full year FY2026–2027, revenue reached ₹61.31 crore and profit touched at ₹22.06 crore.
Read More
Shukra Pharmaceuticals SIP Returns Calculator
₹5,000
Over the past
Total Investment of ₹3,00,000
Monthly SIP of ₹5,000 would have become ₹5,05,72,133 in 5 years with a gain of ₹5,02,72,133 (+16757.38%)
Start SIP

Shukra Pharmaceuticals Fundamental

Market Cap (in crs)

1,377.57

Face Value

1

Turnover (in lacs)

282.19

Key Metrics

Qtr Change %
51.79% Fall from 52W High
-27.1
Dividend yield 1yr %
Low in industry
0.03

Shukra Pharmaceuticals Key Financials

View more
Loading chart...
Shukra Pharmaceuticals Quarterly Revenue
Shukra Pharmaceuticals Yearly Revenue
Shukra Pharmaceuticals Quarterly Net Profit/Loss
Shukra Pharmaceuticals Yearly Net Profit/Loss

Shukra Pharmaceuticals Technical Analysis

Moving Averages Analysis
31.46
Current Price
Bullish Moving Averages
9
Bearish Moving Averages
7
5 EMA
29.70
10 EMA
29.50
12 EMA
29.60
20 EMA
30.00
26 EMA
30.40
50 EMA
32.40
100 EMA
35.00
200 EMA
34.20
Delivery & Volume
Loading chart...

Delivery Volume %

Day

54.40%

Week

59.10%

Month

62.70%

Delivery & Volume

Resistance & Support

30.48
Pivot
Resistance
First Resistance
32.44
Second Resistance
33.43
Third Resistance
35.39
Support
First Support
29.49
Second support
27.53
Third Support
26.54
Relative Strength Index
53.90
Money Flow Index
37.96
MACD
-0.88
MACD Signal
-1.14
Average True Range
1.82
Average Directional Index
22.44
Rate of Change (21)
-6.42
Rate of Change (125)
-17.43

Shukra Pharmaceuticals Peer comparison

Compare

Shukra Pharmaceuticals Shareholding Pattern

Promoter
51%
Domestic Institutions
0.1%
Public
48.9%

Shukra Pharmaceuticals Latest News

05 JUN 2026

Shukra Pharmaceuticals - 524632 - Board Meeting Intimation for Ratification Of Approval For Member''s Resolution Passed In The Extra-Ordinary General Meeting Dated 01St November, 2025

09 MAY 2026

Shukra Pharmaceuticals - 524632 - Announcement under Regulation 30 (LODR)-Newspaper Publication

08 MAY 2026

Q4FY26 & FY26 Result Announced for Shukra Pharmaceuticals .

Shukra Pharmaceuticals Share Price FAQs

You can easily buy Shukra Pharmaceuticals shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.

The 52-week high and low of Shukra Pharmaceuticals share price is ₹65.26 and ₹12.97 as of 5/6/2026.

Please be aware that Shukra Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.